SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-071403
Filing Date
2020-06-09
Accepted
2020-06-09 16:30:29
Documents
3
Period of Report
2020-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2021357d4_8k.htm 8-K 24606
2 EXHIBIT 1.1 tm2021357d4_ex1-1.htm EX-1.1 234873
3 EXHIBIT 5.1 tm2021357d4_ex5-1.htm EX-5.1 15547
  Complete submission text file 0001104659-20-071403.txt   276338
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 20952153
SIC: 2834 Pharmaceutical Preparations